CYTK·Cytokinetics Incorporated

CYTK is currently trading at $77.16, giving Cytokinetics Incorporated a market cap of 10.36B. Today's range spans $75.65–$77.99, with shares opening at $77.20 and moving up $0.31 (0.4%) from the prior close. DailyIQ's technical score sits at 55/100 (HOLD) with a news sentiment reading of 51/100.

Over the past year CYTK has traded between $35.22 and $88.31 - the current price is +119.1% off the 52-week low and -12.6% from the high.

Systematic models flag CYTK as a hold in the current environment - large-cap, the broader market, 10.36B market cap, 55/100 (HOLD), sentiment neutral at 51/100. Price: $77.16 (in the upper portion of its 52-week range). Quant strategies at this size tier typically shift allocation toward higher-momentum names during neutral phases, but maintain a base position given the structural liquidity that prevents disorderly exits. Annual range: $35.22–$88.31.

The 52-week range of $35.22–$88.31 for CYTK provides the structural reference that options traders, systematic funds, and discretionary managers all anchor to, and at $77.16 (in the upper portion of its 52-week range), the stock sits in a zone where the next 5–10% move will likely define which crowd was right. A HOLD signal at 55/100 and neutral news backdrop (51/100) don't break the tie yet, but they narrow the probability distribution toward the upside.